EGFR Mutation Testing

EGFR mutation testing detects mutations in the EGFR gene in cancer tissue, and plays an very important role in determining whether EGFR-targeted tyrosine kinase inhibitors (TKI) are beneficial for treating the tumor.

The full name of EGFR is epidermal growth factor receptor.

An activating EGFR mutation of lung cancer indicates the effectiveness of EGFR-targeted TKI (tyrosine kinase inhibitor) in treating the tumor.

No activating EGFR mutation of lung cancer indicates no effectiveness of EGFR-targeted TKI (tyrosine kinase inhibitor) in treating the tumor (the cancer will not respond to TKI).

Keywords: EGFR Mutation Testing; Epidermal Growth Factor Receptor; Epidermal Growth Factor Receptor Mutation Analysis; erbB-1; HER-1

* The contents of this HTQ Site are for informational and communicational purposes only. The information provided by HTQ, HTQ employees, others appearing on the Site at the invitation of HTQ, or other visitors to the Site is NOT a medical advice.The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the HTQ Site!